MicroRNAs as Biomarkers in Patients With Chagas Disease

Status Completed

Clinical Trial Summary

The purpose of this study is to analyze the efficacy of MicroRNAs as biomarkers on the Chagas Disease prognosis. This analysis will be done through the correlation between the plasmatic levels of this molecule with functional and laboratory tests.

Clinical Trial Description

The patients included in the study must at first sign the written consent. They shall be accompanied in the specialized outpatient clinics for Chagas disease - Hospital São Rafael - Centro de Biotecnologia e Terapia Celular. They will be submitted to several tests, including:

- Collection of Blood samples for biochemical analysis;

- Electrocardiogram;

- Holter Electrocardiogram;

- Echocardiogram;

- Treadmill Test;

- X-Ray Imaging;

- Magnetic Resonance Imaging;

- Evaluation of the quality of life through the application of questionnaires (SF 36 and the Minnesota Living With Heart Failure Questionnaire). ;

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Chagas Disease

Clinical Trial Details

NCT number	NCT01842880
Study type	Observational
Source	Hospital Sao Rafael
Contact
Status	Completed
Phase	N/A
Start date	January 2011
Completion date	December 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01162967` - Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole	Phase 2
Completed	`NCT00023556` - Genetic Architecture of Heart Disease in Rural Brazil	N/A
Active, not recruiting	`NCT04024163` - Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease	Phase 3
Recruiting	`NCT05868005` - Delivering a Multi-disease Screening Tool to Migrant Populations	N/A
Completed	`NCT03892213` - Pharmacokinetic Drug-Drug Interaction Study	Phase 1
Recruiting	`NCT00875173` - Selenium Treatment and Chagasic Cardiopathy (STCC)	Phase 3
Recruiting	`NCT03704181` - Colchicine for Patients With Chagas´ Disease( B1 Stage)	Phase 2
Active, not recruiting	`NCT03378661` - BENDITA BEnznidazole New Doses Improved Treatment and Associations	Phase 2
Completed	`NCT01927224` - Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients	Phase 1
Completed	`NCT01006486` - Outcomes of an Anticoagulation Clinic in an University Hospital	Phase 4
Completed	`NCT00123916` - BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease	Phase 3
Completed	`NCT02516293` - Cardiac Rehabilitation in Chagas Heart Failure	Phase 2/Phase 3
Completed	`NCT02517632` - Physical Exercise Program in Chronic Chagas Heart Disease	Phase 3
Recruiting	`NCT02099903` - Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease	N/A
Completed	`NCT01874795` - Effect of Ganglionar Electrical Stimulation on Central Arterial Pressure	N/A
Completed	`NCT01006473` - Exercise Training in Chagas Cardiomyopathy	Phase 4
Completed	`NCT02386358` - Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial	Phase 3
Not yet recruiting	`NCT05477953` - An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About the Risk of Pregnancy Complications and About the Mother's and Baby's Health
Completed	`NCT02346123` - Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy	N/A
Recruiting	`NCT02295215` - Exercise Training in Patients With Chagasic Heart Disease Without Ventricular Dysfunction	N/A